Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis

International Journal of Cancer

Volumn 95, Issue 2, 2001, Pages 102-107

  Bertario, L ^a   Russo, A ^a   Sala, P ^b   Eboli, M ^a   Giarola, M ^a   D'Amico, F ^c   Gismondi, V ^a   Varesco, L ^b   Pierotti, M A ^a   Radice, P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

APC; Desmoids; Familial adenomatous polyposis; Genotype phenotype; Risk factor

Indexed keywords

ADENOMATOUS POLYP; ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CHILD; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DESMOID TUMOR; EPIDERMOID CYST; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOMA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; CYTOSKELETAL PROTEINS; EPIDERMAL CYST; FAMILY HEALTH; FEMALE; FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; OSTEOMA; PHENOTYPE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REGISTRIES; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 0035917003     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010320)95:2<102::AID-IJC1018>3.0.CO;2-8     Document Type: Article

References (55)

1. Desmoids in familial adenomatous polyposis
2. Identification and characterization of the familial adenomatous polyposis coli gene
3. Mortality in patients with familial adenomatous polyposis
4. Causes of death and postsurgical survival in familial adenomatous polyposis: Results from the Italian registry of familial polyposis writing committee
5. Familial adenomatous polyposis: Desmoid tumors and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444
6. Molecular analysis of the APC gene in 205 families: Extended genotype-phenotype correlations in FAP and evidence for the role of APC aminoacid changes in colorectal cancer predisposition
7. Characterization of 19 novel and six recurring APC mutations in Italian adenomatous polyposis patients, using two different mutation detection tecniques
8. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: Evidence for phenotypic differences in cases with and without identified mutation
9. The analysis of case-control studies
10. Estimating the population attributable risk for multiple risk factors using case-control data
11. Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models
12. Software for attributable risk and confidence interval estimation in case-control studies
13. Desmoid fibromatosis is a clonal process
14. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder
15. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation
16. Desmoids in familial adenomatous polyposis are monoclonal proliferations
17. Desmoid tumors in familial polyposis coli
18. Occurrence of desmoids in patients with familial adenomatous polyposis of the colon
19. Mesenteric fibromatosis complicating familial adenomatous polyposis: Predisposing factors and results of treatment
20. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs: Its rational treatment
21. Operation and abdominal desmoid tumors in familial adenomatous polyposis
22. Desmoid tumours in familial adenomatous polyposis
23. Occurrence of desmoid tumors in familial adenomatous polyposis and results of treatment
24. Desmoid tumors in familial adenomatous polyposis/Gardner's syndrome
25. Desmoid disease in patients with familial adenomatous polyposis
26. Desmoid tumors in patients with familial adenomatous polyposis
27. Estrogen and antiestrogen binding sites in desmoid tumors
28. Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: Results of an in vitro study
29. Antifibromatogenic potency of 9-a fluoro derivative of progesterone
30. Desmoid tumor in the abdominal wall after treatment with high dose estradiol for prostatic cancer
31. Desmoid tumors in familial adenomatous polyposis
32. Desmoid tumors complicating familial adenomatous polyposis
33. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis
34. Familial adenomatous polyposis and other polyposis syndromes
35. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
36. Activation of β-catenin-Tcf signaling in colon cancer by mutations in the β-catenin or APC
37. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene
38. Increased b-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)
39. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis
40. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours
41. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (demoid tumor)
42. A novel case of a sporadic desmoid tumor with mutation of the beta-catenin gene
43. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
44. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis
45. Somatic mutation of APC gene in desmoid tumour in familial adenomatous polyposis
46. Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors
47. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to knudson's "two-hit" hypothesis
48. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene
49. Familial infiltrative fibromatosis (desmoid tumours) (MIM 135290) caused by a recurrent 3′ APC gene mutation
50. A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor
51. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps
52. Extracolonic manifestations of familial adenomatous polyposis: Desmoid tumors and upper gastrointestinal adenomas and carcinomas
53. Treatment of mesenteric desmoid tumors with the anti-oestrogenic agent toremifene: Case histories and an overview of the literature
54. The enigma of desmoid tumors
55. Surgical management of intra-abdominal desmoid tumors